Full Press Release Details
NEW BRUNSWICK, N.J. , Sept. 18, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16 th , to review third-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer, Paul Stoffels , M.D., Chief Scientific Officer (effective Oct.1), and Worldwide Chairman, Pharmaceuticals, Joaquin Duato , Worldwide Chairman, Pharmaceuticals, and Louise Mehrotra , Vice President, Investor Relations, will host the call.
Investors and other interested parties may access the conference call in the following ways:
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
SOURCE Johnson & Johnson